Primary |
Osteoporosis |
36.5% |
Product Used For Unknown Indication |
21.9% |
Hypertension |
6.2% |
Rheumatoid Arthritis |
5.6% |
Osteoporosis Prophylaxis |
4.5% |
Osteoporosis Postmenopausal |
3.4% |
Non-hodgkin's Lymphoma |
2.8% |
Osteopenia |
2.8% |
Atrial Fibrillation |
2.2% |
Blood Pressure |
1.7% |
Osteogenesis Imperfecta |
1.7% |
Respiratory Failure |
1.7% |
Arthralgia |
1.1% |
Back Pain |
1.1% |
Blood Cholesterol Increased |
1.1% |
Bone Disorder |
1.1% |
Breast Cancer |
1.1% |
Compression Fracture |
1.1% |
Deep Vein Thrombosis |
1.1% |
Depression |
1.1% |
|
Osteonecrosis |
15.3% |
Femur Fracture |
10.2% |
Osteonecrosis Of Jaw |
8.5% |
Weight Decreased |
8.5% |
Myalgia |
5.1% |
Pancreatitis Acute |
5.1% |
Pathological Fracture |
5.1% |
Anaphylactic Shock |
3.4% |
Bone Fissure |
3.4% |
Breast Cancer Female |
3.4% |
Cardiac Arrest |
3.4% |
Death |
3.4% |
Foot Fracture |
3.4% |
Hypercalcaemia |
3.4% |
Malaise |
3.4% |
Neoplasm Malignant |
3.4% |
Oesophagitis Ulcerative |
3.4% |
Pain |
3.4% |
Thrombocytopenia |
3.4% |
Anaemia |
1.7% |
|
Secondary |
Product Used For Unknown Indication |
35.9% |
Osteoporosis |
20.3% |
Drug Use For Unknown Indication |
10.4% |
Rheumatoid Arthritis |
8.7% |
Hypertension |
3.9% |
Non-hodgkin's Lymphoma |
3.9% |
Atrial Fibrillation |
2.2% |
Essential Hypertension |
1.7% |
Breast Cancer |
1.3% |
Deep Vein Thrombosis |
1.3% |
Depression |
1.3% |
Hypercholesterolaemia |
1.3% |
Osteopenia |
1.3% |
Pain |
1.3% |
Arrhythmia |
0.9% |
Back Pain |
0.9% |
Compression Fracture |
0.9% |
Dementia |
0.9% |
Diarrhoea |
0.9% |
Gastric Ulcer |
0.9% |
|
Osteonecrosis |
11.8% |
Sepsis |
9.8% |
Rhabdomyolysis |
7.8% |
Tooth Abscess |
7.8% |
Transaminases Increased |
7.8% |
Osteonecrosis Of Jaw |
5.9% |
Renal Cyst |
5.9% |
Renal Failure Acute |
5.9% |
Femur Fracture |
3.9% |
Malaise |
3.9% |
Pathological Fracture |
3.9% |
Somnolence |
3.9% |
Thrombosis |
3.9% |
Tooth Extraction |
3.9% |
Upper Limb Fracture |
3.9% |
Alopecia |
2.0% |
Constipation |
2.0% |
Device Failure |
2.0% |
Fall |
2.0% |
Gastrooesophageal Reflux Disease |
2.0% |
|
Concomitant |
Rheumatoid Arthritis |
23.6% |
Drug Use For Unknown Indication |
19.1% |
Product Used For Unknown Indication |
16.9% |
Osteoporosis |
10.6% |
Hypertension |
7.8% |
Pain |
4.3% |
Depression |
2.4% |
Hiv Infection |
2.1% |
Ankylosing Spondylitis |
2.0% |
Diabetes Mellitus |
1.4% |
Prophylaxis |
1.3% |
Psoriasis |
1.2% |
Breast Cancer |
1.0% |
Coronary Artery Disease |
1.0% |
Thrombosis Prophylaxis |
1.0% |
Urinary Tract Infection |
1.0% |
Atrial Fibrillation |
0.9% |
Premedication |
0.9% |
Dyslipidaemia |
0.8% |
Asthma |
0.7% |
|
Pulmonary Embolism |
10.4% |
Tachycardia |
9.6% |
Pyrexia |
6.4% |
Vomiting |
6.4% |
Osteonecrosis |
5.6% |
Death |
4.8% |
Drug Interaction |
4.8% |
Renal Failure Acute |
4.8% |
Syncope |
4.8% |
Tibia Fracture |
4.8% |
Weight Decreased |
4.8% |
Weight Increased |
4.8% |
Disseminated Tuberculosis |
4.0% |
Pneumonia |
4.0% |
Psoriasis |
4.0% |
Diarrhoea |
3.2% |
Dyspnoea |
3.2% |
Fall |
3.2% |
Myocardial Infarction |
3.2% |
Pseudomembranous Colitis |
3.2% |
|
Interacting |
Product Used For Unknown Indication |
57.1% |
Back Pain |
14.3% |
Osteoporotic Fracture |
14.3% |
Parkinson's Disease |
14.3% |
|
Sleep Disorder |
66.7% |
Osteonecrosis Of Jaw |
33.3% |
|